Live Breaking News & Updates on கார்னெட் கடந்த காலம்

Stay updated with breaking news from கார்னெட் கடந்த காலம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lyra Therapeutics : Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual

New data presented includes:
- First product candidate found to be effective in non-polyp patients in addition to polyp patients in a clinical trial, based on 100% of patients in both groups achieving SNOT-22 MCID at week 24 with LYR-210 (7500µg group) -
- LYR-210 (7500µg) decreased ethmoid opacification at week 24, a measure of disease modification -
- LYR-210 (7500µg) reduced the need for rescue medication -
- Separately, Lyra also reported an analysis showing that LYR-210 (7500µg) achieved statistically significant improvement across 3 cardinal symptoms at week 24 in the LANTERN study -
Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases, today presented data from its Phase 2 LANTERN study of LYR-210, the company’s lead long-acting product candidate fo ....

Robert Kern , Anders Cervin , Maria Palasis , Rodney Williams Memorial Foundation , University Of Queensland , Lyra Therapeutics Inc , Lyra Therapeutics , Combined Otolaryngology Spring Meetings , Professor Anders Cervin , Garnett Passe , Rodney Williams Memorial Foundation Chair , Principal Investigator , Oral Presentation , Non Polyp Patients , Cardinal Symptoms , Chief Medical Officer , Chief Executive Officer , Inc Stock Exchange , Press Release , Both Lyra , ராபர்ட் கர்ன் , ரோட்னி வில்லியம்ஸ் நினைவகம் அடித்தளம் , பல்கலைக்கழகம் ஆஃப் குயின்ஸ்லாந்து , லைரா சிகிச்சை இன்க் , லைரா சிகிச்சை , கார்னெட் கடந்த காலம் ,

Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual

Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Robert Kern , Laurence Watts , Anders Cervin , Kathryn Morris , Maria Palasis , Rodney Williams Memorial Foundation , University Of Queensland , Lyra Therapeutics Inc , Combined Otolaryngology Spring Meetings , Professor Anders Cervin , Garnett Passe , Rodney Williams Memorial Foundation Chair , Principal Investigator , Oral Presentation , Non Polyp Patients , Cardinal Symptoms , Chief Medical Officer , Chief Executive Officer , Private Securities Litigation Reform Act , Annual Report , Lyra Therapeutics , ராபர்ட் கர்ன் , லாரன்ஸ் வாட்ஸ் , க்யாத்ரிந் மோரிஸ் , ரோட்னி வில்லியம்ஸ் நினைவகம் அடித்தளம் , பல்கலைக்கழகம் ஆஃப் குயின்ஸ்லாந்து ,

Treatments That Could Restore Hearing Loss for Millions

Treatments That Could Restore Hearing Loss for Millions
hngn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hngn.com Daily Mail and Mail on Sunday newspapers.

United States , Robert Frisina , Jeanette Pritchard , Bionics Institute , University Of South Florida , Global Center , Rodney William Memorial Foundation , National Institutes Of Health , University Of Southern California , Speech Research , National Institutes , Southern California , Fish Consumption Reduces Risk , Hearing Loss In Women , Garnett Passe , Stanford Medicine , Glue Ear , ஒன்றுபட்டது மாநிலங்களில் , ராபர்ட் ப்ரிசின , ஜீனெட் ப்ரிசர்ட் , பயோனிக்ஸ் நிறுவனம் , பல்கலைக்கழகம் ஆஃப் தெற்கு புளோரிடா , உலகளாவிய மையம் , ரோட்னி வில்லியம் நினைவகம் அடித்தளம் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , பல்கலைக்கழகம் ஆஃப் தெற்கு கலிஃபோர்னியா ,

World-First Therapy Could Restore Hearing Loss for Millions

World-First Therapy Could Restore Hearing Loss for Millions
MELBOURNE Australian scientists are working on a new treatment that could potentially restore hearing for the millions of Australians who lose it within their lifetime.
Although one in six Australians experience hearing loss, there is no drug treatment currently available. This figure will is predicted to rise to one in four by 2050, with the main causes being working in noisy industries such as music, mining, construction, manufacturing, or the military, and age-related hearing loss.
The Garnett Passe and Rodney William Memorial Foundation awarded a $1.25 million grant to the Bionics Institute, which has spent a decade creating a world-first drug to reverse hearing loss. ....

Jeanette Pritchard , Bionics Institute , Professor Of The Bionics Institute Andrew Wise , Rodney William Memorial Foundation , Garnett Passe , Bionics Institute Andrew Wise , Times Photo , Medical Research , The Epoch Times , ஜீனெட் ப்ரிசர்ட் , பயோனிக்ஸ் நிறுவனம் , ப்ரொஃபெஸர் ஆஃப் தி பயோனிக்ஸ் நிறுவனம் ஆண்ட்ரூ பாண்டித்தியம் , ரோட்னி வில்லியம் நினைவகம் அடித்தளம் , கார்னெட் கடந்த காலம் , பயோனிக்ஸ் நிறுவனம் ஆண்ட்ரூ பாண்டித்தியம் , முறை புகைப்படம் , மருத்துவ ஆராய்ச்சி , தி சகாப்தம் முறை ,

A new era of engagement for Griffith

Dr Peter Binks has joined Griffith University as its new Vice President (Industry and External Engagement). Griffith University's new Vice. ....

South Australia , New South Wales , San Francisco , United States , Peter Binks , Peter Bink , Centre For Policy Development , Australia The University , Institute Of Railway Technology , University Partnerships , Sir John Monash Foundation , Griffith University , Defence Science Technology Organisation , Paul Ramsay Foundation , Institute For Glycomics , Garnett Passe Rodney Williams Memorial Foundation , Vice President , External Engagement , Nanotechnology Victoria , John Monash Scholarships , Railway Technology , Defence Science , Technology Organisation , Chief Executive Officer , Business Higher Education Round Table , General Sir John Monash Foundation ,